BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 21056658)

  • 1. Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies.
    El-Laithy HM; Shoukry O; Mahran LG
    Eur J Pharm Biopharm; 2011 Jan; 77(1):43-55. PubMed ID: 21056658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel non-ionic surfactant proniosomes for transdermal delivery of lacidipine: optimization using 2(3) factorial design and in vivo evaluation in rabbits.
    Soliman SM; Abdelmalak NS; El-Gazayerly ON; Abdelaziz N
    Drug Deliv; 2016 Jun; 23(5):1608-22. PubMed ID: 26758033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proniosomes as a carrier system for transdermal delivery of tenoxicam.
    Ammar HO; Ghorab M; El-Nahhas SA; Higazy IM
    Int J Pharm; 2011 Feb; 405(1-2):142-52. PubMed ID: 21129461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano-proniosomes enhancing the transdermal delivery of mefenamic acid.
    Wen MM; Farid RM; Kassem AA
    J Liposome Res; 2014 Dec; 24(4):280-9. PubMed ID: 24779560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proniosomal transdermal therapeutic system of losartan potassium: development and pharmacokinetic evaluation.
    Thakur R; Anwer MK; Shams MS; Ali A; Khar RK; Shakeel F; Taha EI
    J Drug Target; 2009 Jul; 17(6):442-9. PubMed ID: 19527115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentials of proniosomes for improving the oral bioavailability of poorly water-soluble drugs.
    Song S; Tian B; Chen F; Zhang W; Pan Y; Zhang Q; Yang X; Pan W
    Drug Dev Ind Pharm; 2015 Jan; 41(1):51-62. PubMed ID: 24111828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, evaluation, and NMR characterization of vinpocetine microemulsion for transdermal delivery.
    Hua L; Weisan P; Jiayu L; Ying Z
    Drug Dev Ind Pharm; 2004 Jul; 30(6):657-66. PubMed ID: 15285339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethosomes as delivery system for transdermal administration of vinpocetine.
    Mao YT; Hua HY; Zhang XG; Zhu DX; Li F; Gui ZH; Zhao YX
    Pharmazie; 2013 May; 68(5):381-2. PubMed ID: 23802438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and evaluation of proniosomes containing lornoxicam.
    Madan JR; Ghuge NP; Dua K
    Drug Deliv Transl Res; 2016 Oct; 6(5):511-8. PubMed ID: 27255375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized preparation of vinpocetine proliposomes by a novel method and in vivo evaluation of its pharmacokinetics in New Zealand rabbits.
    Xu H; He L; Nie S; Guan J; Zhang X; Yang X; Pan W
    J Control Release; 2009 Nov; 140(1):61-8. PubMed ID: 19651165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proniosomes as a drug carrier for transdermal delivery of ketorolac.
    Alsarra IA; Bosela AA; Ahmed SM; Mahrous GM
    Eur J Pharm Biopharm; 2005 Apr; 59(3):485-90. PubMed ID: 15760729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proniosomes in transdermal drug delivery.
    Rahimpour Y; Kouhsoltani M; Hamishehkar H
    Curr Pharm Des; 2015; 21(20):2883-91. PubMed ID: 25925111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal carvedilol proniosomal gel using experimental design.
    Aboelwafa AA; El-Setouhy DA; Elmeshad AN
    AAPS PharmSciTech; 2010 Dec; 11(4):1591-602. PubMed ID: 21063815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the bioavailability of an antihypertensive drug by transdermal protransfersomal system: formulation and in vivo study.
    Morsi NM; Aboelwafa AA; Dawoud MHS
    J Liposome Res; 2018 Jun; 28(2):137-148. PubMed ID: 28264602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery.
    Alsarra IA
    J Microencapsul; 2009 May; 26(3):272-8. PubMed ID: 18720197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Optimization of microemulsion containing vinpocetine and its physicochemical properties].
    Li H; Pan WS; Wu Z; Li JY; Xia LX
    Yao Xue Xue Bao; 2004 Sep; 39(9):681-5. PubMed ID: 15606013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of Dissolution and Skin Permeability of Pentazocine by Proniosomes and Niosomal Gel.
    Madni A; Rahim MA; Mahmood MA; Jabar A; Rehman M; Shah H; Khan A; Tahir N; Shah A
    AAPS PharmSciTech; 2018 May; 19(4):1544-1553. PubMed ID: 29470828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel vesicular transdermal delivery of nifedipine - preparation, characterization and in vitro/in-vivo evaluation.
    Yasam VR; Jakki SL; Natarajan J; Venkatachalam S; Kuppusamy G; Sood S; Jain K
    Drug Deliv; 2016; 23(2):619-30. PubMed ID: 25005581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proniosomes as drug carriers.
    Sankar V; Ruckmani K; Durga S; Jailani S
    Pak J Pharm Sci; 2010 Jan; 23(1):103-7. PubMed ID: 20067875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single Intravenous Dose of Novel Flurbiprofen-Loaded Proniosome Formulations Provides Prolonged Systemic Exposure and Anti-inflammatory Effect.
    Verma P; Prajapati SK; Yadav R; Senyschyn D; Shea PR; Trevaskis NL
    Mol Pharm; 2016 Nov; 13(11):3688-3699. PubMed ID: 27632682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.